Repigmentation of vitiligo-associated eyelash leukotrichia with topical tofacitinib. | JAAD Case Rep;16: 90-91, 2021 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Repigmentation of vitiligo-associated eyelash leukotrichia with topical tofacitinib.

Kim, Sa Rang; Craiglow, Brittany G.

Affiliation

Kim SR; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
Craiglow BG; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.

JAAD Case Rep ; 16: 90-91, 2021 Oct.

Article in En | MEDLINE | ID: mdl-34541274

Key words

JAK inhibitor; JAK, Janus kinase; Janus kinase; leukotrichia; pediatric; therapy; tofacitinib; topical; treatment; vitiligo

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: JAAD Case Rep Year: 2021 Document type: Article Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: JAAD Case Rep Year: 2021 Document type: Article Country of publication: United States